🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Biomarkers from circulating cell-free tumor DNA in peripheral blood will id...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2017-05-02
Trial ID
NCT03228810
Treatments Being Tested
The overall objective of this study is to acquire ultrasound images, spectr...
Status
Suspended
Location
The James Buchanan Brady Urological Institute and Department of Urology
Start Date
2018-10-10
Trial ID
NCT03734575
Treatments Being Tested
This phase II trial tests how well pertuzumab, trastuzumab, hyaluronidase-z...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2024-03-08
Trial ID
NCT05730712
This study relates to men with hypogonadism, a condition describing a defic...
Status
Unknown
Location
Beaumont Hospital
Start Date
2023-03-12
Trial ID
NCT05773183
Treatments Being Tested
The primary objective of this study is to collect material for study's to a...
Status
Terminated
Location
Rutgers Cancer Institute of New Jersey
Start Date
2008-12-12
Trial ID
NCT00991315
This phase II trial tests leuprolide acetate alone versus in combination wi...
Status
Not Yet Recruiting
Location
Mayo Clinic in Rochester
Start Date
2026-07-01
Trial ID
NCT07650240
This study is being conducted to collect and analyze biospecimens (blood an...
Status
Completed
Location
Johns Hopkins SKCCC
Start Date
2014-11
Trial ID
NCT02657863
Treatments Being Tested
Due to the rapid growth, tumour demand for oxygen is often higher than what...
Status
Unknown
Location
The Christie NHS Foundation Trust
Start Date
2021-10-03
Trial ID
NCT05702619
Treatments Being Tested
Background: Insomnia is associated with difficulty sleeping. The drug zolp...
Status
Terminated
Location
National Institutes of Health Clinical Center
Start Date
2019-01-22
Trial ID
NCT03436745
This phase II trial evaluates whether genetic testing in prostate cancer is...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2025-02-06
Trial ID
NCT06632977